📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
EIKO LIFESCIENCES LIMITEDEIKOSpecialty Chemicals
Open
50.98
High
54
Low
50.98
Close
51.98
Volume
3901
Exchange
bse
Time
01-Apr-2026

Outlook

Score:  

3

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Eiko Lifesciences is  
None
Estimated Stoploss of Eiko Lifesciences is ₹  
50.98
Eiko Lifesciences has a  
Bullishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Eiko Lifesciences is  
Unpredictableℹ
. 

Trend

Eiko Lifesciences is in  
Sideways trendℹ
. 
Price of Eiko Lifesciences is  
Upℹ
 by  

0.44

%. 
Target
Buy @ 

48.84

Sell @ 

55.1

Current @ 

51.98

Volume

The trade volumes of Eiko Lifesciences have become  
Deficientℹ
Though the volume trend for Eiko Lifesciences appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Eiko Lifesciences is  

Down

 by  

53.62

% 

Valuation

The current market price of Eiko Lifesciences is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 66cr and total assets worth ₹ 66cr, the balance sheet of Eiko Lifesciences is:  
Balancedℹ
. 
Cashflow
Eiko Lifesciences has  
Insufficientℹ
 cash flow because there is  

Shortage

 of  

₹ 1cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

10.53% i.e. ₹ 2cr earned in operatingℹ
57.89% i.e. ₹ 11cr spent in investingℹ
31.58% i.e. ₹ 6cr earned in financingℹ
0% in otherℹ
Income
The income of Eiko Lifesciences is  

₹ 11cr

 and  

Profit

 is :  

₹ 1cr

(*Sep 2025)

Eiko Lifesciences Profit is up by:  

0

% and Income is Up by:  

10

% 

(*Sep 2025)

The income of Eiko Lifesciences is  

₹ 10cr

 and  

Profit

 is :  

₹ 1cr

(*Jun 2025)

Eiko Lifesciences Profit is up by:  

0

% and Income is Down by:  

9.09

% 

(*Jun 2025)

The income of Eiko Lifesciences is  

₹ 11cr

 and  

Profit

 is :  

₹ 1cr

(*Mar 2025)

Eiko Lifesciences Profit is up by:  

100

% and Income is Up by:  

57.14

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.